Engineers develop nanoparticles that cross the blood-brain barrier

There are currently few good treatment options for glioblastoma, an aggressive type of brain cancer with a high fatality rate. One reason that the disease is so difficult to treat is that most chemotherapy drugs can’t penetrate the blood vessels that

Related Keywords

United Kingdom ,Roger Kamm ,Joelle Straehla ,Paula Hammond ,Jenniferc Johnson ,Foundation For Childhood Cancer Research ,Koch Institute ,National Cancer Institute ,Department Of Chemical Engineering ,Harvard Medical School ,Institute Professor ,Helen Gurley Brown Presidential Initiative ,Cancer Research United Kingdom Brain Tumour Award ,Agreement Award ,Ludwig Center ,Proceedings Of The National Academy Sciences ,Koch Institute For Integrative Cancer Research ,Dana Farber Cancer Institute ,Clinical Investigator ,Integrative Cancer Research ,Dana Farber Cancer ,Cynthia Hajal ,National Academy ,Chemical Engineering ,Ida Green Distinguished Professor ,Mechanical Engineering ,Nature Protocolspaper ,Cooperative Agreement Award ,Horizon Award ,Defense Peer Reviewed Cancer Research Program ,Molecular Oncology Graduate Fellowship ,Rally Foundation ,Childhood Cancer ,Koch Institute Support ,National Cancer ,